Hydrocortisone Patent Expiration

Hydrocortisone is Used for treating adrenal insufficiency. It was first introduced by Merck And Co Inc in its drug Hydrocortone on Approved Prior to Jan 1, 1982. Other drugs containing Hydrocortisone are Khindivi, Alkindi Sprinkle, Cortef, Cortril, Cortenema, Hydrocortisone, Cort-Dome. 80 different companies have introduced drugs containing Hydrocortisone.

Hydrocortisone Patents

Given below is the list of patents protecting Hydrocortisone, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Khindivi	US11904046		Feb 23, 2043	Eton
Khindivi	US12133914		Feb 23, 2043	Eton
Alkindi Sprinkle	US9649280	Composition comprising hydrocortisone	May 12, 2034	Eton
Alkindi Sprinkle	US9675559	Treatment of adrenal insufficiency	Jan 10, 2033	Eton
Alkindi Sprinkle	US9717740	Treatment of adrenal insufficiency	Nov 19, 2032	Eton

Hydrocortisone has petitions filed by 1 petitioner: Akorn Animal Health Inc.

Details of Hydrocortisone's suitability petitions are listed below.

Petitioner	Action	Date of Action	Description

Akorn Animal Health Inc.	Approved

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List